Severe Infantile Transaldolase Deficiency

Main Article Content

Khaled Alqoaer
Ziad Asaad
Maisa Halabi

Abstract

Transaldolase TALDO deficiency is a rare autosomal recessive disorder of the pentose phosphate pathway. It has variable presentations with poor outcome when present early in life. We present a young Saudi infant with a fatal early presentation of TALDO deficiency.

Keywords:
Transaldolase, pentose phosphate pathway

Article Details

How to Cite
Alqoaer, K., Asaad, Z., & Halabi, M. (2019). Severe Infantile Transaldolase Deficiency. Asian Journal of Pediatric Research, 2(4), 1-5. Retrieved from http://journalajpr.com/index.php/AJPR/article/view/30112
Section
Case Report

References

Verhoeven NM, Huck JH, Roos B, Struys EA, Salomons GS, Douwes AC, Van der Knaap MS, Jakobs C. Transaldolase deficiency: Liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet. 2001;68(5): 1086-92.

Perl A. The pathogenesis of transaldolase deficiency. IUBMB Life. 2007;59(6):365-73. Review.

Wamelink MM, Smith DE, Jansen EE, Verhoeven NM, Struys EA, Jakobs C. Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis. 2007;30(5):735-42.

Eyaid W, Al Harbi T, Anazi S, Wamelink MM, Jakobs C, Al Salammah M, Al Balwi M, Alfadhel M, Alkuraya FS. Transaldolase deficiency: Report of 12 new cases and further delineation of the phenotype J Inherit Metab Dis. 2013;36(6):997-1004.

Rodan LH, Berry GT. N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels. JIMD Rep. 2017;31:73-77.

Lipiński P, Pawłowska J, Stradomska T, Ciara E, Jankowska I, Socha P, Tylki-Szymańska A. Long-Term Systematic Monitoring of Four Polish Transaldolase Deficient Patients. JIMD Rep. 2018;42:79-87.

Lee-Barber J, English TE, Britton JF, Sobreira N, Goldstein J, Valle D, Bjornsson HT. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency. JIMD Rep. 2019;44:9-15.

Williams M, Valayannopoulos V, Altassan R, Chung WK, Heijboer AC, Keng WT, Lapatto R, McClean P et al. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients. J Inherit Metab Dis. 2019; 42(1):147-158.

Loeffen YG, Biebuyck N, Wamelink MM, Jakobs C, Mulder MF, Tylki-Szymańska A, Fung CW, Valayannopoulos V, Bökenkamp A. Nephrological abnormalities in patients with transaldolase deficiency. Nephrol Dial Transplant. 2012;27(8):3224-7.

Vas G, Conkrite K, Amidon W, Qian Y, Bánki K, Perl A. Study of transaldolase deficiency in urine samples by capillary LC-MS/MS. J Mass Spectrom. 2006;41(4): 463-9.

Wamelink MM, Struys EA, Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis. 2008;31(6): 703-17.